Clinical Trial News and Research

RSS

Telemedicine could have a profound impact on the treatment of stroke patients throughout the world

Researchers at the University of California, San Diego Medical Center say that their first-of-its-kind study of a telemedicine program which transports stroke specialists via computer desktop or even laptop to the patient's bedside, using highly sophisticated video, audio and Internet technology, could have an immediate and profound impact on the treatment of stroke patients throughout the world.

3 Aug 2008

Warfarin may prevent liver failure in hepatitis C

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.

31 Jul 2008

Promising new therapy for Alzheimer's

NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today the nine-month interim results of an ongoing Phase II clinical trial of GAMMAGARD Intravenous Immunoglobulin (IGIV) for Alzheimer's disease at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago.

From Baxter International Inc. 30 Jul 2008

Australian Alzheimer's trial published in the Lancet

Prana Biotechnology Limited announced today the publication of the results of its Phase 2a clinical trial on Alzheimer's disease patients in The Lancet Neurology journal.

29 Jul 2008

Alzheimer's disease patients show improvement in trial of new drug

A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease.

29 Jul 2008

New Alzheimer's studies show advances against different treatment targets

Two studies related to experimental Alzheimer's therapies reported positive results today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) in Chicago.

28 Jul 2008

Clinical trials to examine mushrooms' cancer-fighting properties

The role of mushrooms in reducing the risk of breast and prostate cancers and in stunting the growth of these cancers will be tested shortly with the start of human clinical trials at the City of Hope research centre in California.

27 Jul 2008

Xylitol 'gummy bears' may prevent dental problems

The tooth-protecting sugar substitute xylitol has been incorporated into gummy bears to produce a sweet snack that may prevent dental problems.

24 Jul 2008

First-of-its-kind study examines whether fat tissues from different areas of the body vary in stem cell concentration

Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body, reports a Brazilian-based study in August's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

23 Jul 2008

Bioscience fund GBS invests US$6m in Xenome

Biopharmaceutical company Xenome Limited today announced it has received a convertible note placement of US$6 million from GBS Venture Partners, a Melbourne based life sciences specialist that invests in unlisted and listed high growth companies involved in innovative technologies.

23 Jul 2008

New cartilage repair gel developed by University of Bradford

The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis.

22 Jul 2008

Gilead initiates phase III trial of Elvitegravir

Gilead Sciences, Inc. has announced that it has begun enrolling patients in a Phase III clinical trial of its investigational antiretroviral agent elvitegravir (GS 9137), a novel oral integrase inhibitor that is being evaluated for the treatment of HIV-1 infection.

22 Jul 2008

Use of rheumatoid arthritis drug to treat Alzheimer's causes concern

New research into the treatment of Alzheimer's disease using a popular rheumatoid arthritis drug has caused some concern.

22 Jul 2008

Pain-relieving gel eases mammography discomfort

The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of Radiology.

22 Jul 2008

Abiraterone new drug for aggressive prostate cancer the best thing in 70 years

Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years.

22 Jul 2008

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

Anadis Ltd, a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel.

22 Jul 2008

Study shows promising results in deep brain stimulation for treatment-resistant depression

New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.

21 Jul 2008

First human tests of an injectable vaccine grown in genetically engineered plants

Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

21 Jul 2008

CUPID cannabinoid MS study reaches milestone

The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.

21 Jul 2008